Stage IVB Prostate Cancer AJCC v8 Not Yet Recruiting Phase 2 Trials for Vorinostat (DB02546)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06145633Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate CancerTreatment